TECOGEN INC.·4

Jun 30, 8:30 PM ET

Galiteva Angelina 4

4 · TECOGEN INC. · Filed Jun 30, 2026

Research Summary

AI-generated summary of this filing

Updated

TECOGEN (TGEN) Director Angelina Galiteva Receives 25,000-Share Award

What Happened

  • Angelina Galiteva, a director of TECOGEN, was granted a derivative award of 25,000 shares on June 26, 2026. The award is reported at $5.17 per share for a total grant value of $129,250 (transaction code A — grant/award). This is an acquisition/compensation award, not an open-market purchase.

Key Details

  • Transaction date: 2026-06-26; Form 4 filed: 2026-06-30 (Accession 0001537435-26-000042).
  • Grant size and value: 25,000 shares × $5.17 = $129,250.
  • Reported as a derivative award (code A).
  • Vesting: footnote states vests 25% per year (i.e., typically fully vested after four years).
  • Shares owned after transaction: not specified in the filing.
  • No indication in the filing that this was a sale or cash exercise.

Context

  • This is a compensation-style award subject to vesting; such grants are common for directors and reflect compensation arrangements rather than immediate buying or selling of stock. The vesting schedule means the shares will become owned/transferable over time (25% each year).

Insider Transaction Report

Form 4
Period: 2026-06-26
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-06-26$5.17/sh+25,000$129,25025,000 total
    Exercise: $5.17From: 2027-06-26Exp: 2036-06-26Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]Vests 25% per year
Signature
/s/ Angelina Galiteva|2026-06-30

Documents

1 file
  • 4
    wk-form4_1782865848.xmlPrimary

    FORM 4